Publ eng 2003-10.doc

PUBLICATIONS
ARTICLES
1. Olsson OAT, Ahlquist B, Gustafsson B. A new β2-adrenoceptor agonist with α1- adrenoceptor blocking properties. Acta Pharmacol Toxicol 1981;48:340-8. 2. Olsson OAT, Ahlquist B, Gustafsson B, Persson G. The effects in myometrial preparations of D2343, a β2-adrenoceptoragonist possessing α1-receptor blocking qualities. Acta Pharmacol Toxicol 1984;55:391-397. 3. Olsson OAT, Gustafsson B. The effect of D2343 in transmurally stimulated rabbit isthmus muscle. Acta Pharmacol Toxicol 1985;56:427-430. 4. Gustafsson B, Persson CGA. In vitro interactions between xanthines and β-receptor agonists in trachea and the heart. In: Current Clinical Practice Series No. 19. Anti-asthma xanthines and adenosine. Proceedings of a symposium in Copenhagen, Feb 22-23, 1985. Eds. Andersson K-E, Persson CG. 1985;214-9. 5. Persson CGA, Gustafsson B, Kjellin G. Tracheal relaxation and adenosine antagonism by 1- and/or 3-alkylxanthines. In: Current Clinical Practice Series No. 19. Anti-asthma xanthines and adenosine. Proceedings of a symposium in Copenhagen, Feb 22-23, 1985. Eds. K-E Andersson and CGA Persson. 1985;447-452. 6. Persson CGA, Gustafsson B. Tracheal relaxation from combinations of xanthines and of a β2-receptor agonist and xanthines. Lung 1986;164:33-40. 7. Persson CGA, Erjefält I, Gustafsson B. Xanthines - symptomatic or prophylactic in asthma? Agents Actions Suppl. Directions for new anti-asthma drugs. 1988;23:137-55. 8. Persson CGA, Andersson PT, Gustafsson B. Budesonide reduces sensitivity to antigen but does not alter baseline tone or responsiveness to carbachol, terbutaline, and enprofylline in IgE-sensitized guinea-pig tracheae. Int Arch Allergy Appl Immunol 1989;88:381-5. 9. Gustafsson B, Persson CGA. Effect of three weeks´ treatment with budesonide on in vitro contractile and relaxant airway effects in the rat. Thorax 1989;44:24-7. 10. Persson CGA, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990;92:2:148-153. 11. Gustafsson GB, Persson CGA. Asymmetrical effects of increase in hydrostatic pressure on macromolecular movement across the airway mucosa. Clin Exp Allergy 1991;21;1:121-126. 12. Persson CGA, Erjefält I, Alkner U, Baumgarten C, Greiff L, Gustafsson B, Lets A, Pipkorn U, Sundler F, Svensson C, Wollmer P. Plasma exudation/transudation as a first line mucosal defence. Clin Exp Allergy 1991;21:1:17-24. 13. Gustafsson B, Persson CGA. Effect of different bronchodilators on airway smooth muscle responsiveness to contractile agents. Thorax 1991;46:360-365. 14. Persson CGA, Gustafsson B, Luts A, Sundler F, Erjefält I. Toluene diisocyanate produces an increase in airway tone that outlasts the inflammatory exudation phase. Clin Exp Allergy 1991;21;6:715-724. 15. Gustafsson B, Persson CGA. Allergen-induced mucosal exudation into rat distal ileum and its inhibition by budesonide. Scand J Gastoenterol. 1992;27:587-593. 16. Persson CGA, Gustafsson B, Erjefält JS, Sundler F. Mucosal exudation of plasma is a non-injurious intestinal defence mechanism. Allergy Eur J Allergy Clin Immunol 1993;48:581-586. 17. Persson CGA, Greiff L, Andersson M, Erjefält I, Svensson C, Alkner U, Gustafsson B. Mucosal exudation of plasma in asthma and rhinitis. In: Asthma and Rhinitis. Eds. Busse WW, Holgate ST. Blackwell Scientific Publications. 1995; 733-741. 18. Persson CGA, Andersson M, Greiff L, Svensson C, Erjefält JS, Sundler F, Wollmer P, Alkner U, Erjefält I, Gustafsson B, Linden M, Nilsson M. Airway permeability. Clin Exp Allergy 1995;23:807-814. 19. Miller-Larsson A, Gustafsson B, Brattsand R, Persson CGA. Upptag och retention av steroider i ileum hos råtta. Gastro Focus 1995;5:26. 20. Erjefält JS, Andersson P, Gustafsson B et al. Allergen challenge-induced extravasation of plasma proteins in mouse airways. Clin Exp Allergy 1998;28:1013-1020. 21. Gustafsson B, Miller-Larsson A, Persson CGA. Topical and oral anti-inflammatory activity of budesonide compared with prednisolone, using allergen-induced gut mucosal exudation of plasma as a marker. Scand J Gastroenterol 2001;36:1062-1066. 22. Miller-Larsson A/Gustafsson B, Persson CGA, Brattsand R. Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat. Aliment Pharmacol Ther 2001;15(12):2019-2025. ABSTRACTS
1. Olsson OAT, Ahlquist B, Gustafsson B. A β2-adrenoceptor agonist with α1-adrenoceptor blocking properties. Acta Pharmacol Toxicol 1981;49:83 [Abstract]. 2. Finney MJ, Gustafsson B, Karlsson JA, Persson CGA, Sonmark B. Effects of terbutaline, theophylline and enprofylline in tracheas, bronchi and lung strips contracted by proposed asthma mediators. Br J Pharmacol 1983;80:710P [Abstract]. 3. Gustafsson B, Erjefält I, Luts A, Persson CGA. Hydrostatiskt tryck subepitelialt ger atraumatiskt och reversibelt inträde av plasma i luftvägslumen. XVII Nordiska kongressen i allergologi, 1990 [Abstract]. 4. Persson CGA, Gustafsson B. Allergen-induced plasma exudation into the gut. Clin Exp Allergy Eur J Allergy Clin Immunol 1992;22;1:130(P30) [Abstract]. 5. Gustafsson B, Persson CGA. Allergen-induced mucosal exudation of plasma into rat ileum and its inhibition by budesonide. Allergy Eur J Allergy Clin Immunol 1992;12;47:247 [Abstract]. 6. Gustafsson B, Erjefält JS, Sundler F, Persson CGA. Exudation of plasma across an intact mucosa in gut allergy. Allergy Eur J Allergy Clin Immunol 1993;48;15(Suppl):89 [Abstract]. 7. Persson C, Andersson M, Greiff L, Svensson C, Åkerlund A, Alkner U, Erjefält I, Gustafsson B, Linden M, Wollmer P, Erjefält J, Sundler F. Inflammatory responses of mucosal end-organs. Allergy Eur J Allergy Clin Immunol 1993;48;15(Suppl):19 [Abstract]. 8. Gustafsson B, Erjefält JS, Sundler F, Persson CGA. Exudation of plasma across an intact mucosa in gut allergy and its inhibition by glucocorticoids. Falk Symposium Series no 72, 1993 [Abstract]. 9. Gustafsson B, Persson CGA. Oral budesonide exhibits greater topical selectivity than prednisolone in a rat ileal inflammation model. Gastroenterology 1994;106;4(2):A696 10. Persson CGA, Gustafsson B. Absorption- and exudation-permeability across the gut mucosa in vivo. Differential actions of allergen and acetic acid. Gastroenterology 1994;106;4(2):A752 [Abstract]. 11. Miller-Larsson A, Gustafsson B, Brattsand R, Persson CGA. Mucosal and submucosal ileal uptake of topical budesonide in absence and presence of inflammatory exudation of plasma. Gastroenterology 1994;106;4(2):A735 [Abstract]. 12. Gustafsson B, Persson CGA. Budesonide has a greater topical selectivity than prednisolone in rat allergic ileum. Allergy Clin Immunol News 1994;6(Suppl 2):340 [Abstract]. 13. Persson CGA, Gustafsson B. Absorption- and exudation-permeability of rat ileal mucosa in vivo. Differential actions of allergen and acetic acid. Allergy Clin Immunol News 1994;6;2:340 [Abstract]. 14. Gustafsson B, Miller-Larsson A, Brattsand R, Persson CGA. Onset of action and topical antiinflammatory efficacy of budesonide in allergen challenged rat ileum. Gastroenterology 1995;108;4:A830 [Abstract]. 15. Miller-Larsson A, Gustafsson B, Brattsand R, Persson CGA. Mucosal uptake and retention of steroids in rat ileum. Possible explanation of topical efficacy in inflammatory bowel diseases (IBD). Gastroenterology 1995;108;4:A876 [Abstract]. 16. KAL Lundblad, B Gustafsson, U Johansson, P Ottosson, PT Persson, C Brange, C Zackrisson. Airways hyperreactivity does not correlate with morphometry in allergic mice. Resp Crit Care Med 1999; 159(3): A408 [Abstract]. 17. Miller-Larsson A, Gustafsson B, Hjertberg E, Persson CGA, Brattsand R. Reversible formation of lipophilic fatty acid esters of the glucocorticoid budesonide in rat ileal tissue in vivo. Gut 2001;49(Suppl III)[Abstract]. 18. Miller-Larsson A, Gustafsson B, Jerre A, Wieslander E, Brattsand R. Intestinal esterification of budesonide may prolong glucocorticoid activity. Gastroenterology 2002;122;4:A396 [Abstract].

Source: http://www.biofocus.se/pdf/Publications.pdf